CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: An Italian case-control study

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Antognelli, Cinzia ^a   Del Buono, Chiara ^a   Ludovini, Vienna ^b   Gori, Stefania ^b   Talesa, Vincenzo N ^a   Crinò, Lucio ^b   Barberini, Francesco ^a   Rulli, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CYTOCHROME P450 17; GLUTATHIONE TRANSFERASE P1; LACTOYLGLUTATHIONE LYASE; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN; STEROID 17ALPHA MONOOXYGENASE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENARCHE; OXIDATIVE STRESS; PARITY; PREMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BREAST TUMOR; CANCER STAGING; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; MENOPAUSE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; RISK FACTOR; STATISTICAL MODEL; TIME;

AGED; ARYLDIALKYLPHOSPHATASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; ITALY; LACTOYLGLUTATHIONE LYASE; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; TIME FACTORS;

EID: 65649125590     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-115     Document Type: Article

References (51)

1. Sant M Francisci S Capocaccia R Verdecchia A Allemani C Berrino F Time trends of breast cancer survival in Europe in relation to incidence and mortality Int J Cancer 2006, 119(10):2417-22. 10.1002/ijc.22160 16964611
2. Feigelson HS Henderson BE Estrogens and breast cancer Carcinogenesis 1996, 17(11):2279-84. 10.1093/carcin/17.11.2279 8968038
3. Russo J Hasan Lareef M Balogh G Guo S Russo IH Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells J Steroid Biochem Mol Biol 2003, 87(1):1-25. 10.1016/S0960-0760(03)00390-X 14630087
4. Ambrosone CB Oxidants and antioxidants in breast cancer Antioxid Redox Signal 2000, 2(4):903-17. 10.1089/ars.2000.2.4-903 11213491
5. Gönenç A Erten D Aslan S Akinci M Simşek B Torun M Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease Cell Biol Int 2006, 30(4):376-80. 10.1016/j.cellbi.2006.02.005 16616293
6. Sener DE Gonenc A Akinci M Torun M Lipid peroxidation and total antioxidant status in patients with breast cancer Cell Biochem Funct 2007, 25(4):377-82. 10.1002/cbf.1308 16447143
7. Tesarová P Kalousová M Trnková B Soukupová J Argalásová S Mestek O Petruzelka L Zima T Carbonyl and oxidative stress in patients with breast cancer - is there a relation to the stage of the disease? Neoplasma 2007, 54(3):219-24. 17447853
8. Tesarová P Kalousová M Jáchymová M Mestek O Petruzelka L Zima T Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer Cancer Invest 2007, 25(8):720-5. 10.1080/07357900701560521 18058469
9. Picado-Leonard J Miller WL Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): Similarity with the gene for P450c21 DNA 1987, 6(5):439-48. 10.1089/dna.1987.6.439 3500022
10. Whalen R Boyer TD Human glutathione S-transferases Semin Liver Dis 1998, 18(4):345-58. 10.1055/s-2007-1007169 9875553
11. Feigelson HS Coetzee GA Kolonel LN Ross RK Henderson BE A polymorphism in the CYP17 gene increases the risk of breast cancer Cancer Res 1997, 57(6):1063-5. 9067272
12. Feigelson HS McKean-Cowdin R Coetzee GA Stram DO Kolonel LN Henderson BE Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates Cancer Res 2001, 61(2):785-9. 11212283
13. Chakraborty A Murthy NS Chintamani C Bhatnagar D Mohil RS Sharma PC Saxena S CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients J Hum Genet 2007, 52(2):159-65. 10.1007/s10038-006-0095-0 17235448
14. Chen Y Gammon MD Teitelbaum SL Britton JA Terry MB Shantakumar S Eng SM Wang Q Gurvich I Neugut AI Santella RM Ahsan H Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: Results from the Long Island Breast Cancer Study Project Carcinogenesis 2008, 29(4):766-71. 10.1093/ carcin/bgn042 18281250
15. Sarmanová J Sůsová S Gut I Mrhalová M Kodet R Adámek J Roth Z Soucek P Breast cancer: Role of polymorphisms in biotransformation enzymes Eur J Hum Genet 2004, 12(10):848-54. 10.1038/ sj.ejhg.5201249 15280903
16. Van Emburgh BO Hu JJ Levine EA Mosley LJ Perrier ND Freimanis RI Allen GO Rubin P Sherrill GB Shaw CS Carey LA Sawyer LR Miller MS Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer Oncol Rep 2008, 19(5):1311-21. 18425393
17. Helzlsouer KJ Selmin O Huang HY Strickland PT Hoffman S Alberg AJ Watson M Comstock GW Bell D Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer J Natl Cancer Inst 1998, 90(7):512-8. 10.1093/jnci/90.7.512 9539246
18. Maugard CM Charrier J Pitard A Campion L Akande O Pleasants L Ali-Osman F Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier Int J Cancer 2001, 91(3):334-9. 10.1002/ 1097-0215(200002)9999:9999<::AID-IJC1057>3.0.CO;2-H 11169956
19. Mitrunen K Jourenkova N Kataja V Eskelinen M Kosma VM Benhamou S Vainio H Uusitupa M Hirvonen A Steroid metabolism gene CYP17 polymorphism and the development of breast cancer Cancer Epidemiol Biomarkers Prev 2000, 9(12):1343-8. 11142420
20. Verla-Tebit E Wang-Gohrke S Chang-Claude J CYP17 5′-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study Breast Cancer Res 2005, 7(4):R455-64. 1175058 15987450 10.1186/bcr1027
21. Ambrosone CB Moysich KB Furberg H Freudenheim JL Bowman ED Ahmed S Graham S Vena JE Shields PG CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors Breast Cancer Res 2003, 5(2):R45-51. 154148 12631398 10.1186/bcr570
22. Ye Z Parry JM The CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis Mutagenesis 2002, 17(2):119-26. 10.1093/mutage/17.2.119 11880540
23. Hefler LA Tempfer CB Grimm C Lebrecht A Ulbrich E Heinze G Leodolter S Schneeberger C Mueller MW Muendlein A Koelbl H Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women Cancer 2004, 101(2):264-9. 10.1002/ cncr.20361 15241822
24. Krajinovic M Ghadirian P Richer C Sinnett H Gandini S Perret C Lacroix A Labuda D Sinnett D Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions Int J Cancer 2001, 92(2):220-5. 10.1002/ 1097-0215(200102)9999:9999<::AID-IJC1184>3.0.CO;2-H 11291049
25. Mitrunen K Jourenkova N Kataja V Eskelinen M Kosma VM Benhamou S Vainio H Uusitupa M Hirvonen A Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer Cancer Epidemiol Biomarkers Prev 2001, 10(3):229-36. 11303592
26. Millikan R Pittman G Tse CK Savitz DA Newman B Bell D Glutathione S-transferases M1, T1, and P1 and breast cancer Cancer Epidemiol Biomarkers Prev 2000, 9(6):567-73. 10868690
27. Vogl FD Taioli E Maugard C Zheng W Pinto LF Ambrosone C Parl FF Nedelcheva-Kristensen V Rebbeck TR Brennan P Boffetta P Glutathione S-transferases M1, T1, and P1 and breast cancer: A pooled analysis Cancer Epidemiol Biomarkers Prev 2004, 13(9):1473-9. 15342448
28. Mackness B Durrington PN Mackness MI Human serum paraoxonase Gen Pharmacol 1998, 31(3):329-36. 10.1016/S0306-3623(98)00028-7 9703197
29. Shih DM Gu L Xia YR Navab M Li WF Hama S Castellani LW Furlong CE Costa LG Fogelman AM Lusis AJ Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis Nature 1998, 394(6690):284-7. 10.1038/28406 9685159
30. Humbert R Adler DA Disteche CM Hassett C Omiecinski CJ Furlong CE The molecular basis of the human serum paraoxonase activity polymorphism Nat Genet 1993, 3(1):73-6. 10.1038/ng0193-73 8098250
31. Adkins S Gan KN Mody M La Du BN Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes Am J Hum Genet 1993, 52(3):598-608. 1682165 7916578
32. Leviev I Deakin S James RW Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations J Lipid Res 2001, 42(4):528-35. 11290824
33. Gallicchio L McSorley MA Newschaffer CJ Huang HY Thuita LW Hoffman SC Helzlsouer KJ Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease Cancer Detect Prev 2007, 31(2):95-101. 10.1016/j.cdp.2007.02.004 17428620
34. Stevens VL Rodriguez C Pavluck AL Thun MJ Calle EE Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort Cancer Epidemiol Biomarkers Prev 2006, 15(6):1226-8. 10.1158/1055-9965.EPI-05-0930 16775186
35. Thornalley PJ The glyoxalase system: Towards functional characterisation and a role in disease processes Glutathione Metabolism and Physiological Functions Boca Raton: CRC Press 1990, 135-143.
36. Junaid MA Kowal D Barua M Pullarkat PS Sklower Brooks S Pullarkat RK Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor Am J Med Genet A 2004, 131(1):11-7. 1360505 15386471 10.1002/ajmg.a.30349
37. Nowell SA Ahn J Ambrosone CB Gene-nutrient interactions in cancer etiology Nutr Rev 2004, 62:427-38. 15622715
38. Huang CS Chern HD Chang KJ Cheng CW Hsu SM Shen CY Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYPA1, and COMT: A multigenis study on cancer susceptibility Cancer Research 1999, 59:4870-4875. 10519398
39. Salama SA Kamel M Awad M Nasser AH Al-Hendy A Botting S Arrastia C Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: Protective effect of catechol-O-methyltransferase Int J Cancer 2008, 123(6):1246-54. 10.1002/ ijc.23653 18566989
40. Yu BP Cellular defenses against damage from reactive oxygen species Physiol Rev 1994, 74(1):139-162. 8295932
41. Kalapos MP The tandem of free radicals and methylglyoxal Chem Biol Interact 2008, 171(3):251-271. 10.1016/j.cbi.2007.11.009 18164697
42. Singletary SE Allred C Ashley P Bassett LW Berry D Bland KI Borgen PI Clark G Edge SB Hayes DF Hughes LL Hutter RV Morrow M Page DL Recht A Theriault RL Thor A Weaver DL Wieand HS Greene FL Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol 2002, 20(17):3628-36. 10.1200/JCO.2002.02.026 12202663
43. Willett C Walter American Association for Cancer Research Diet and Cancer: One View at the Start of the Millennium Cancer Epidemiology Biomarkers & Prevention 2000, 10:3-8.
44. Nebert DW McKinnon RA Puga A Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer DNA and Cell Biology 1996, 15:273-280. 10.1089/dna.1996.15.273
45. Hayes JD Pulford DJ The glutathione S-transferase supergene family: regulation of GST and the contribution of the enzyme to cancer chemoprotection and drug resistance Crit Rev Biochem Mol Biol 1995, 30:445-60. 10.3109/10409239509083491 8770536
46. Feigelson HS Shames LS Pike MC Coetzee GA Stanczyk FZ Henderson BE Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations Cancer Res 1998, 58(4):585-7. 9485002
47. Thompson PA Shields PG Freudenheim JL Stone A Vena JE Marshall JR Graham S Laughlin R Nemoto T Kadlubar FF Ambrosone CB Genetic polymorphism in catechol-o-metyltransferase, menopausal status and breast cancer risk Cancer Res 1998, 58:2107-2110. 9605753
48. Ali-Osman F Akande O Antoun G Mao JX Buolamwini J Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins J Biol Chem 1997, 272(15):10004-12. 10.1074/jbc.272.15.10004 9092542
49. Ferrè N Camps J Fernandez-Ballart J Arija V Murphy MM Ceruelo S Biarnés E Vilella E Tous M Joven J Regulation of Serum Paraoxonase Activity by Genetic, Nutritional, and Lifestyle Factors in the General Population Clin Chem 2003, 49(9):1491-1497. 10.1373/ 49.9.1491 12928230
50. Salanti G Amountza G Ntzani EE Ioannidis JP Hardy-Weinberg equilibrium in genetic association studies: An empirical evaluation of reporting, deviations, and power Eur J Hum Genet 2005, 13(7):840-8. 10.1038/ sj.ejhg.5201410 15827565
51. Spurdle AB Webb PM Purdie DM Chen X Green A Chenevix-Trench G Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: Risk of ovarian cancer by histological type Carcinogenesis 2001, 22(1):67-72. 10.1093/carcin/22.1.67 11159743